Adderall shortages in US: FDA cites ADHD drug shipment delays

The drug, commonly known by the brand name Adderall or Adderall IR, is an FDA-approved treatment for ADHD and narcolepsy.

WASHINGTON — The Food and Drug Administration explained a nationwide shortage of Adderall, a drug used to treat ADHD, on Wednesday.

The FDA cited that Teva, one of the largest manufacturers of the drug, was experiencing shipping delays. Other generic versions of the instant release amphetamine mixed salts also existed Having trouble meeting demand in the US market.

The drug, commonly known by the brand name Adderall or Adderall IR, is an FDA-approved treatment for attention-deficit/hyperactivity disorder and narcolepsy.

Patients prescribed Adderall should speak with their healthcare providers to find alternative treatment until supply is restored, the FDA said.

The agency said extended-release versions of mixed-salt amphetamines are possible alternatives for those who need the scarce drugs.

Last week, a said a spokesman for Teva Pharmaceutical Industries Ltd. to Bloomberg that the supply shortages would probably last for the next two to three months.

“Teva has an active supply of both branded and generic Adderall and continues to regularly produce and fill the channel at levels in excess of historical demand,” the company told TEGNA in an emailed statement. “It’s possible that some people may run into a backlog (temporarily) depending on timing and demand, but those are temporary.”

Teva said it expects “a stock recovery in the coming months.”

In addition to Teva, US regulators have listed other companies with supply shortages, including Epic Pharma LLC, Rhodes Pharmaceuticals LP and SpecGX LLC.

The number of prescriptions for Adderall and generic equivalents has increased in recent years, with the number increasing by 16% from 2019 The New York Times reported.

A Survey earlier this year by the National Community Pharmacists Association found that 64% of community pharmacists had “Trouble getting Adderall.”

The survey, based on more than 350 responses from pharmacy owners and managers, also showed that around 80% of pharmacists were experiencing supply shortages. The troubles also started earlier this summer with a labor shortage at the company, the company said American Journal of Managed Care.

Teva said it is working closely with our manufacturing facility and the DEA to see what additional volume we may be able to support in the future.

https://www.kvue.com/article/news/health/nationwide-adderall-shortage/507-0550ab97-aff5-41cf-bf7a-972bf416f907 Adderall shortages in US: FDA cites ADHD drug shipment delays

Laura Coffey

World Time Todays is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@worldtimetodays.com. The content will be deleted within 24 hours.

Related Articles

Back to top button